APA

Asgharzadeh M., Jigheh Z. A., Kafil H. S., Farhoudi M., Oskouei D. S., Khaki-Khatibi F., Fadaee M., Vegari A., Asgharzadeh V., Najafi-Ghalelou N., Poor B. M. & Rashedi J. (20210615). Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran. : Endocrine, metabolic & immune disorders drug targets.

Chicago

Asgharzadeh Mohammad, Jigheh Zahra A, Kafil Hossein S, Farhoudi Mehdi, Oskouei Daryoush S, Khaki-Khatibi Fatemeh, Fadaee Manouchehr, Vegari Ali, Asgharzadeh Vahid, Najafi-Ghalelou Nima, Poor Behroz M and Rashedi Jalil. 20210615. Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran. : Endocrine, metabolic & immune disorders drug targets.

Harvard

Asgharzadeh M., Jigheh Z. A., Kafil H. S., Farhoudi M., Oskouei D. S., Khaki-Khatibi F., Fadaee M., Vegari A., Asgharzadeh V., Najafi-Ghalelou N., Poor B. M. and Rashedi J. (20210615). Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran. : Endocrine, metabolic & immune disorders drug targets.

MLA

Asgharzadeh Mohammad, Jigheh Zahra A, Kafil Hossein S, Farhoudi Mehdi, Oskouei Daryoush S, Khaki-Khatibi Fatemeh, Fadaee Manouchehr, Vegari Ali, Asgharzadeh Vahid, Najafi-Ghalelou Nima, Poor Behroz M and Rashedi Jalil. Association of Interleukin-1 and Inteleukin-1 Receptor Antagonist Gene Polymorphisms with Multiple Sclerosis in Azeri Population of Iran. : Endocrine, metabolic & immune disorders drug targets. 20210615.